Authors

• Ryon P. Graf (ORCID: https://orcid.org/0000-0002-8065-4148)
• Alan Haruo Bryce (ORCID: https://orcid.org/0000-0002-0206-3895)
• Umang Swami (ORCID: https://orcid.org/0000-0003-3518-0411)
• Zeynep İrem Özay (ORCID: https://orcid.org/0000-0002-4827-9042)
• Gerald Li (ORCID: https://orcid.org/0000-0002-5617-6262)
• Douglas I. Lin (ORCID: https://orcid.org/0000-0003-0105-9760)
• Rana R. McKay (ORCID: https://orcid.org/0000-0002-0581-7963)
• Julia A. Elvin (ORCID: https://orcid.org/0000-0001-9476-9563)
• Júlia C.F. Quintanilha (ORCID: https://orcid.org/0000-0001-6908-4474)
• Nicolas Sayegh (ORCID: https://orcid.org/0000-0003-1924-8148)
• Chadi Hage Chehade (ORCID: https://orcid.org/0009-0008-6735-5777)
• Jeffrey S. Ross (ORCID: https://orcid.org/0000-0001-8494-2596)
• Tian Zhang (ORCID: https://orcid.org/0000-0001-8914-3531)
• Neeraj Agarwal (ORCID: https://orcid.org/0000-0003-1076-0428)

Institutions

• City Of Hope National Medical Center (US)
• SUNY Upstate Medical University (US)
• University of Utah (US)
• Huntsman Cancer Institute (US)
• Boston Foundation (US)
• GlobalFoundries (United States) (US)
• University of California San Diego (US)
• AstraZeneca (South Korea) (KR)
• Southwestern Medical Center (US)
• City of Hope (US)
• AstraZeneca (Brazil) (BR)
• Veterans Medical Research Foundation of San Diego (US)
• Foundation Medicine (United States)
• The University of Texas Southwestern Medical Center (US)

Publication Details

Journal

Clinical Cancer Research

Published

2025-12-04

DOI

https://doi.org/10.1158/1078-0432.ccr-25-2750

Primary Topic

Prostate Cancer Treatment and Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• Flatiron Health
• Foundation Medicine